Life Science Tools Global Market Report 2026

Life science tools are specialized resources and systems designed to support the study, investigation, and understanding of living organisms and their biological processes. They are vital for enabling researchers to obtain accurate and reliable data, which is essential for analyzing and interpreting various aspects of life sciences. By providing the means to explore complex biological mechanisms, these tools are a fundamental component of scientific research and the advancement of knowledge in life sciences.

The primary categories of life science tools include instruments, consumables, and services. Instruments are critical laboratory devices used to analyze biological samples and conduct precise scientific experiments. They employ a variety of technologies, such as polymerase chain reaction (PCR) and quantitative PCR (qPCR), Sanger sequencing, separation technologies, flow cytometry, nucleic acid microarrays, mass spectrometry, and more. These tools find applications in drug discovery and development, clinical diagnostics, genomic and proteomic research, cell biology research, and other areas, serving multiple end users, including academic and research institutions, biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, contract research organizations (CROs), and government and regulatory agencies.

Tariffs are impacting the life science tools market by increasing costs for imported instruments, reagents, and consumables, affecting the affordability of high-precision equipment. Segments like polymerase chain reaction (PCR) systems, sequencing instruments, and chromatography systems are particularly affected, with Asia-Pacific regions including China and India facing significant import duties. This has resulted in higher operational costs and slowed equipment adoption. On the positive side, tariffs have encouraged local manufacturing, innovation in alternative materials and instruments, and strengthened domestic production capabilities.

The life science tools market research report is one of a series of new reports from The Business Research Company that provides life science tools market statistics, including life science tools industry global market size, regional shares, competitors with a life science tools market share, detailed life science tools market segments, market trends and opportunities, and any further data you may need to thrive in the life science tools industry. This life science tools market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The life science tools market size has grown rapidly in recent years. It will grow from $201.37 billion in 2025 to $229.1 billion in 2026 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to reliance on traditional laboratory instruments, limited access to high-quality reagents and consumables, increasing pharmaceutical and biotech research activities, growth in academic and research institutions, adoption of manual laboratory processes.

The life science tools market size is expected to see rapid growth in the next few years. It will grow to $379.95 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to integration of automation and smart laboratory equipment, increasing investment in genomics and proteomics research, rising demand for personalized medicine, expansion of clinical diagnostics and drug discovery applications, adoption of cloud-based data analytics and digital lab solutions. Major trends in the forecast period include increasing adoption of high-throughput instruments and automation, rising demand for advanced consumables and reagents, expansion of genomic, proteomic, and cell biology research, growing focus on contract research organizations (cros), enhanced quality control and calibration services for life science tools.

The increasing demand for biopharmaceuticals is anticipated to drive growth in the life science tools market in the coming years. Biopharmaceuticals are medical drugs produced through biotechnology, utilizing biological sources such as living cells or organisms to develop therapies including proteins, antibodies, and vaccines. Their rising demand is largely attributed to their effectiveness in treating complex and chronic diseases that traditional small-molecule drugs cannot sufficiently address. Life science tools support the development and manufacturing of biopharmaceuticals by providing essential technologies for research, analysis, and quality control throughout the drug production process, ensuring precision, efficiency, and regulatory compliance. For example, according to Cardinal Health Inc., a US-based healthcare company, as of January 2022, the US had 33 FDA-approved biosimilar products, with 21 available on the market. By 2023, the number of FDA-approved biosimilars had increased to 40, with 25 commercially available. Thus, the growing demand for biopharmaceuticals is driving expansion in the life science tools market.

Leading companies in the life science tools market are focusing on creating innovative solutions, such as automated sequencing platforms, to improve efficiency, accuracy, and accessibility in genetic analysis, thereby accelerating research and clinical diagnostics. Automated sequencing platforms are advanced systems that perform DNA or RNA sequencing with minimal manual input through robotics and software, increasing throughput, reducing errors, and enabling faster, more reliable genetic research and diagnostics. For instance, in October 2024, Illumina Inc., a US-based biotechnology company, launched the MiSeq i100 series, its fastest and simplest benchtop sequencers designed to make next-generation sequencing more accessible to a broader range of laboratories. The MiSeq i100 and MiSeq i100 Plus Systems offer room-temperature kit storage and shipping, eliminating delays caused by reagent thawing and enabling same-day sample-to-analysis workflows. These platforms deliver rapid sequencing with run times as short as four hours, cost-effective consumables, and user-friendly, push-button workflows suitable for applications in microbiology, infectious disease, and oncology. This development highlights the market's trend toward efficient, scalable, and easy-to-use sequencing tools that empower both researchers and clinicians.

In July 2025, Bio-Rad Laboratories Inc., a US-based life sciences and clinical diagnostics technology company, acquired Stilla Technologies for an undisclosed sum. Through this acquisition, Bio-Rad aims to strengthen its presence in the biotechnology sector by incorporating Stilla's next-generation digital PCR systems, consumables, and assays into its offerings, enhancing its capabilities in oncology diagnostics, cell and gene therapy, and infectious disease testing across both research and clinical settings. Stilla Technologies SA, based in France, specializes in digital PCR instruments and molecular diagnostic solutions.

Major companies operating in the life science tools market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Lonza Group Ltd., Illumina Inc., Sartorius AG, Shimadzu Corporation, Revvity Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Eppendorf AG, Tecan Group Ltd., Bio-Techne Corporation, Takara Bio Inc., GenScript Biotech Corporation, 10x Genomics Inc., Hamilton Company.

North America was the largest region in the life science tools market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science tools market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the life science tools market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The life science tools market consists of revenues earned by entities by providing services such as laboratory testing and analysis, bioprocessing equipment supply, clinical trial support services, and quality control. The market value includes the value of related goods sold by the service provider or included within the service offering. The life science tools market also includes sales of western blotting, bioreactors, centrifuges, and microfluidics and lab-on-a-chip devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Life Science Tools Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses life science tools market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for life science tools ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The life science tools market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Instruments; Consumables; Services
• 2) By Technology: Polymerase Chain Reaction(PCR) And Quantitative Polymerase Chain Reaction (qPCR); Sanger Sequencing; Separation Technologies; Flow Cytometry; Nucleic Acid Microarray; Mass Spectrometry; Other Technologies
• 3) By Application: Drug Discovery And Development; Clinical Diagnostics; Genomic And Proteomic Research; Cell Biology Research; Other Applications
• 4) By End-User: Academic And Research Institutions; Biotechnology And Pharmaceutical Companies; Hospitals And Diagnostic Laboratories; Contract Research Organizations (CROs); Government And Regulatory Agencies
• Subsegments:
• 1) By Instruments: Microscopes; Sequencers; Analyzers; Spectrometers; Centrifuges; Chromatography Systems; Laboratory Automation Equipment
• 2) By Consumables: Reagents; Kits; Culture Media; Pipettes And Tips; Plasticware; Laboratory Chemicals; Assay Kits
• 3) By Services: Calibration Services; Maintenance And Repair; Laboratory Testing Services; Consulting Services; Training And Support; Research And Development Services
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck KGaA; Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies Inc.; Lonza Group Ltd.; Illumina Inc.; Sartorius AG; Shimadzu Corporation; Revvity Inc.; Waters Corporation; Bio-Rad Laboratories Inc.; Bruker Corporation; Eppendorf AG; Tecan Group Ltd.; Bio-Techne Corporation; Takara Bio Inc.; GenScript Biotech Corporation; 10x Genomics Inc.; Hamilton Company.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.